Wait, is weed legal now? - Post Reports Recap

Podcast: Post Reports

Published: 2025-12-22

Duration: 18 minutes

Guests: David Ovalle

Summary

President Trump has ordered federal agencies to reclassify marijuana from a Schedule I to a Schedule III drug, potentially altering its legal status and implications for research, businesses, and federal policy.

What Happened

For over 50 years, marijuana has been classified by the U.S. government as a Schedule I drug, which places it alongside LSD and heroin in terms of danger and lack of medicinal value. However, President Trump has issued an executive order to reschedule marijuana to Schedule III, which implies a recognition of its potential therapeutic effects.

This move, while significant, does not equate to federal legalization or decriminalization of marijuana. It primarily reduces restrictions, potentially easing the process for scientists to conduct medical research and allowing cannabis companies to claim standard business tax write-offs.

Health reporter David Ovalle explained that the Controlled Substances Act categorizes drugs based on their potential for abuse and medicinal value, with Schedule I being the most restrictive. The reclassification aims to align federal policy with the growing acceptance of marijuana's medicinal benefits in various states.

Despite these changes, Ovalle noted that marijuana remains a controlled substance federally, and its regulation will largely depend on state laws. The reclassification could prompt the FDA to regulate marijuana products more stringently, similar to other Schedule III substances.

David Ovalle highlighted that the move originated from a Biden administration proposal that had stalled, and Trump is essentially following through on what was previously set in motion. This decision also reflects the broader public consensus against harsh penalties for marijuana use.

There is considerable Republican opposition to this reclassification, with some conservatives expressing concerns about health impacts and the message it sends. Congressman Pete Sessions, for instance, argued that this move might benefit criminal organizations and lead to public health issues.

Overall, while the reclassification represents a shift in federal policy, the actual impact on marijuana availability and consumer prices will depend on state-level regulations and any potential litigation that may arise to challenge the change.

Key Insights